ATE401091T1 - Modifizierte ganzzell-, zellextrakt- und omv- basierte impfstoffe - Google Patents
Modifizierte ganzzell-, zellextrakt- und omv- basierte impfstoffeInfo
- Publication number
- ATE401091T1 ATE401091T1 AT04768807T AT04768807T ATE401091T1 AT E401091 T1 ATE401091 T1 AT E401091T1 AT 04768807 T AT04768807 T AT 04768807T AT 04768807 T AT04768807 T AT 04768807T AT E401091 T1 ATE401091 T1 AT E401091T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccines
- cell
- based vaccines
- modified whole
- omv
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 108010062802 CD66 antigens Proteins 0.000 abstract 2
- 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 abstract 2
- 241000040340 Oat mosaic virus Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 229940124590 live attenuated vaccine Drugs 0.000 abstract 1
- 229940023012 live-attenuated vaccine Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323709.6A GB0323709D0 (en) | 2003-10-09 | 2003-10-09 | Modified whole cell,cell extract and omv-based vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE401091T1 true ATE401091T1 (de) | 2008-08-15 |
Family
ID=29433617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04768807T ATE401091T1 (de) | 2003-10-09 | 2004-10-08 | Modifizierte ganzzell-, zellextrakt- und omv- basierte impfstoffe |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070154495A1 (de) |
| EP (1) | EP1687011B1 (de) |
| JP (1) | JP2007508537A (de) |
| AT (1) | ATE401091T1 (de) |
| AU (1) | AU2004279990B2 (de) |
| CA (1) | CA2541834C (de) |
| DE (1) | DE602004015141D1 (de) |
| DK (1) | DK1687011T3 (de) |
| ES (1) | ES2310753T3 (de) |
| GB (1) | GB0323709D0 (de) |
| PT (1) | PT1687011E (de) |
| WO (1) | WO2005035733A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011027956A2 (ko) | 2009-09-04 | 2011-03-10 | 주식회사이언메딕스 | 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델 |
| WO2011027971A2 (ko) * | 2009-09-01 | 2011-03-10 | 주식회사이언메딕스 | 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법 |
| KR101488902B1 (ko) * | 2009-10-08 | 2015-02-03 | 주식회사이언메딕스 | 실내 공기유래 세포밖 소포체를 포함하는 조성물 및 이의 용도 |
| JP2011169834A (ja) * | 2010-02-19 | 2011-09-01 | Kansai Bunri Sogo Gakuen | 病原性グラム陰性細菌由来脂質小胞の検出方法および検出システム |
| KR20160101521A (ko) * | 2015-02-17 | 2016-08-25 | 이화여자대학교 산학협력단 | 세균 유래 세포밖 소포체를 이용한 호흡기 염증성 질환의 진단방법 |
| WO2018042015A1 (en) | 2016-09-02 | 2018-03-08 | Glaxosmithkline Biologicals Sa | Vaccines for neisseria gonorrhoeae |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
| GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
| CA2493124C (en) * | 2002-08-02 | 2014-04-29 | Glaxosmithkline Biologicals S.A. | Vaccine |
-
2003
- 2003-10-09 GB GBGB0323709.6A patent/GB0323709D0/en not_active Ceased
-
2004
- 2004-10-08 PT PT04768807T patent/PT1687011E/pt unknown
- 2004-10-08 DE DE602004015141T patent/DE602004015141D1/de not_active Expired - Lifetime
- 2004-10-08 US US10/575,070 patent/US20070154495A1/en not_active Abandoned
- 2004-10-08 AU AU2004279990A patent/AU2004279990B2/en not_active Ceased
- 2004-10-08 EP EP04768807A patent/EP1687011B1/de not_active Expired - Lifetime
- 2004-10-08 CA CA2541834A patent/CA2541834C/en not_active Expired - Fee Related
- 2004-10-08 ES ES04768807T patent/ES2310753T3/es not_active Expired - Lifetime
- 2004-10-08 WO PCT/GB2004/004274 patent/WO2005035733A2/en not_active Ceased
- 2004-10-08 JP JP2006530598A patent/JP2007508537A/ja active Pending
- 2004-10-08 DK DK04768807T patent/DK1687011T3/da active
- 2004-10-08 AT AT04768807T patent/ATE401091T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004279990B2 (en) | 2010-04-01 |
| CA2541834A1 (en) | 2005-04-21 |
| GB0323709D0 (en) | 2003-11-12 |
| CA2541834C (en) | 2012-09-04 |
| EP1687011B1 (de) | 2008-07-16 |
| WO2005035733A3 (en) | 2005-12-29 |
| AU2004279990A1 (en) | 2005-04-21 |
| WO2005035733A2 (en) | 2005-04-21 |
| DE602004015141D1 (de) | 2008-08-28 |
| US20070154495A1 (en) | 2007-07-05 |
| JP2007508537A (ja) | 2007-04-05 |
| ES2310753T3 (es) | 2009-01-16 |
| DK1687011T3 (da) | 2008-11-10 |
| EP1687011A2 (de) | 2006-08-09 |
| PT1687011E (pt) | 2008-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20023829L (no) | Proteosom influensavaksine | |
| EA200601671A1 (ru) | Идентификация собственных и чужеродных антигенов, вовлечённых в аутоиммунные заболевания | |
| ECSP066683A (es) | Vacuna para mejorar el crecimiento, a base de epítopes neutralizantes | |
| EA201170493A1 (ru) | Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот | |
| MXPA02005639A (es) | Induccion de respuestas celulares iinmunologicas al virus de papiloma humano y utilizacion de composiciones de peptidos y acidos nucleico. | |
| SI1644484T1 (sl) | Avtologne samo-toleranco inducirajoče celice monocitnega izvora in njihova uporaba v farmacevtskihpripravah | |
| UA103751C2 (ru) | Иммуногенный пептид для иммунотерапии | |
| CR8231A (es) | Anticuerpos rg1 y uso de los mismos | |
| CY1113650T1 (el) | Συντηρημενα αντιγονα neisseria | |
| ATE454901T1 (de) | Verfahren zur erhaltung zellimmuneantworten gegen proteinen | |
| NZ595707A (en) | Cancer antigen helper peptide | |
| LT2287195T (lt) | Antikūnai, atpažįstantys pan-kir2dl nk receptorius, ir jų panaudojimas diagnostikoje bei terapijoje | |
| EA201590597A1 (ru) | Коровый белок вируса гепатита в и поверхностный антигенный белок и содержащая их вакцина | |
| ATE517340T1 (de) | Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren | |
| EA200602137A1 (ru) | Гидрогелевые препараты интерферона | |
| WO2023094713A3 (en) | Coronavirus vaccine | |
| BRPI0607605A2 (pt) | moléculas imunogênicas | |
| ATE460176T1 (de) | Mikrosomvakzin | |
| EA200801427A1 (ru) | Молекулы антитела со специфической активностью в отношении интерлейкина-6 (ил-6) человека | |
| ATE473236T1 (de) | Antigene von piscirickettsia salmonis und deren verwendung | |
| EA200900738A1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
| WO2007016185A3 (en) | Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination | |
| ATE465753T1 (de) | Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden | |
| DE602004015141D1 (de) | Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe | |
| ATE513561T1 (de) | Veränderung des th1/th2-gleichgewichts in spalt- grippeimpfstoffen mit adjuvantien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1687011 Country of ref document: EP |